Revolutionizing Research and Clinical Trials: Innovating Today for a Healthier Tomorrow
In an era defined by rapid advancements in technology and science, healthcare research and clinical trials are undergoing a transformative shift. At the heart of this revolution is data—vast, diverse, and ever-growing—and the collaborative efforts of stakeholders...
Driving Change in Cancer Care: How Real-World Evidence is Revolutionizing Health Technology Assessments and Regulatory Standards
The use of real-world evidence (RWE) in regulatory decision-making and health technology assessments (HTA) is gaining traction, particularly in the evolving landscape of oncology pharmacotherapeutics in Europe where navigating the drug approval and market access...
With new diversity guidance, EHR data plus AI will be critical
In June 2024, the U.S. Food and Drug Administration (FDA) issued draft guidance outlining the need for “Diversity Action Plans” as a way for clinical trial sponsors to demonstrate their consideration toward trial representation. Affecting phase 3 studies, and others...
Optimizing Cancer Clinical Trials with External Control Arms
Cancer clinical trials have long been the cornerstone of advancements in oncology, guiding the development of new therapies and improving patient outcomes. However, traditional clinical trials often face challenges such as lengthy durations, high costs, and difficulty...
Network Spotlight: Penn State Clinical and Translational Science Institute (CTSI)
Each quarter, our Healthcare Partnership Team recognizes a healthcare organization (HCO) for its exemplary collaboration with TriNetX. Join us in congratulating Penn State Clinical and Translational Science Institute (CTSI) as our newest Network Spotlight HCO! Due to...
Pharmacovigilance Reimagined: How Real-World Data, AI, and Regulatory Changes Are Shaping the Future
In the evolving landscape of pharmacovigilance (PV), market authorization holders (MAHs) face mounting pressure to integrate real-world data (RWD) into their safety monitoring processes. This shift is propelled by a combination of regulatory initiatives and the...
Is Your Real-World Data Research-Ready?
Optimizing Data Quality in Pharmacoepidemiologic Studies Authors: Jeffrey Brown, PhD, Chief Scientific Officer at TriNetX and Matvey Palchuk, MD, Chief Medical Informatics Officer at TriNetX Pharmacoepidemiology, the study of the use and effects of drugs in large...
Network Spotlight: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori (IRST)
We are privileged to acknowledge Istituto Romagnolo per lo Studio dei Tumori Dino Amadori (IRST) for their valuable collaboration with TriNetX. IRST, the first Italian healthcare organization (HCO) to utilize the TriNetX LIVE™ platform, is leveraging the power of...